Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2012
11/28/2012EP2526092A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
11/28/2012EP2526090A2 New anti-malarial agents
11/28/2012CN102803257A Insecticidal Compounds
11/28/2012CN102803248A Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
11/28/2012CN102803247A Novel fumarate salts of a histamine H3 receptor antagonist
11/28/2012CN102803246A HEDGEHOG pathway antagonists and therapeutic applications thereof
11/28/2012CN102803245A Novel Indole, Indazole And Benzimidazole Arylamides As P2X3 And/or P2X2/3 Antagonists
11/28/2012CN102803227A Morpholinylquinazolines
11/28/2012CN102803225A Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/28/2012CN102803224A Novel azabicyclohexanes
11/28/2012CN102803223A Cyclic compound having substituted phenyl group
11/28/2012CN102803218A 4 -aminopicolinates And Their Use As Herbicides
11/28/2012CN102803216A Heterocyclic antiviral compounds
11/28/2012CN102803214A New compounds, pharmaceutical composition and methods relating thereto
11/28/2012CN102803210A Azetidinyl diamides as monoacylglycerol lipase inhibitors
11/28/2012CN102797150A Halamine antibacterial agent, its preparation method and application
11/28/2012CN102796081A Pyrimidine sulphonamide derivatives as chemokine receptor modulators
11/28/2012CN102796079A Method for preparing flumatinib mesylate
11/28/2012CN102796078A Pantoprazole compound, preparation methods and pharmaceutical preparations thereof
11/28/2012CN102796077A Compound with diuretic effect
11/28/2012CN102796076A Preparation method for nicotine standard substance
11/28/2012CN102796075A Benzocycloheptenes derivative as well as preparation method and medical application thereof
11/28/2012CN102796074A Method for preparing imatinib mesylate intermediate
11/28/2012CN102796041A Quinoline thiourea compound, and synthesis method and application thereof
11/28/2012CN101768161B Nitrogen-containing heterocyclic compound with pesticidal activity, preparation and application thereof
11/28/2012CN101667626B Organic electroluminescent devices and metal complex compounds
11/28/2012CN101268050B Isotopically substituted pantoprazole
11/28/2012CN101123964B G-protein coupled receptor(GPR116) agonists and use thereof for treating obesity and diabetes
11/28/2012CN101107244B Organic compound, charge transport material and organic electroluminescent element containing the same
11/27/2012US8318944 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/27/2012US8318943 Sorbitol/dexlansoprazole co-crystals and method for making same
11/27/2012US8318935 Organic compounds 75074
11/27/2012US8318791 Substituted imidazole derivatives
11/27/2012US8318777 2-pyridinylethylcarboxamide derivatives and their use as fungicides
11/27/2012US8318775 N-(heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
11/27/2012US8318773 Isoindoline compounds and methods of their use
11/27/2012US8318769 Substituted sulfonamide compounds
11/27/2012US8318768 Bronchodilating alpha, beta-unsaturated isoquinoline amides
11/27/2012US8318767 Substituted imidazoles as bombesin receptor subtype-3 modulators
11/27/2012US8318759 Pyrrolidine derivatives as NK3 receptor antagonists
11/27/2012US8318752 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoyl-methyl)piperidin-4-yl]oxy}quinazoline, its pharmaceutically acceptable salts, and pharmaceutical compositions comprising the same
11/27/2012US8318750 Organic compounds
11/27/2012US8318749 Quinazoline derivatives as NK3 receptor antagonists
11/27/2012US8318748 Cathepsin cysteine protease inhibitors
11/27/2012US8318746 Nitrogen-containing five-membered heterocyclic compound
11/27/2012US8318742 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/27/2012US8318736 HIV inhibiting 5,6-substituted pyrimidines
11/27/2012US8318735 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
11/27/2012US8318730 Fused hetrocyclic compounds
11/27/2012US8318720 Acrylamide derivatives as Fab I inhibitors
11/27/2012US8318718 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
11/27/2012US8318443 Reagent for detecting an analyte
11/27/2012CA2702482C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2702467C Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
11/27/2012CA2629570C Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
11/27/2012CA2598521C Heterocyclylamide-substituted imidazoles
11/27/2012CA2579002C Pyridyl inhibitors of hedgehog signalling
11/27/2012CA2568725C Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists
11/27/2012CA2567662C Compounds and compositions as protein kinase inhibitors
11/27/2012CA2525214C Macrocyclic quinazoline derivatives as antiproliferative agents
11/27/2012CA2515790C Heterocyclic kinase inhibitors
11/27/2012CA2487805C Peptide deformylase inhibitors
11/27/2012CA2467374C Indole-2-carboxamides as factor xa inhibitors
11/27/2012CA2449830C New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
11/22/2012WO2012158810A1 Tyrosine kinase inhibitors
11/22/2012WO2012158568A1 Compounds for stem cell differentiation
11/22/2012WO2012158413A2 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012WO2012158399A1 Condensed 2 - carbamoylpyridazinones as potassium channel modulators
11/22/2012WO2012157537A1 Light-emitting element material and light-emitting element
11/22/2012WO2012156938A1 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
11/22/2012WO2012156936A1 Substituted indole derivatives for the treatment of immunological disorders
11/22/2012WO2012156756A2 New compounds
11/22/2012WO2012156334A1 Inhibitors of bruton's tyrosine kinase
11/22/2012WO2012155806A1 4-aminoquinazoline derivatives and uses thereof
11/22/2012WO2012155516A1 Aggregation-inducing luminescent penta-substituted tetrahydropyrimidine and use thereof
11/22/2012WO2012155199A1 Amine derivatives as potassium channel blockers
11/22/2012WO2012131656A3 Compounds for use as therapeutic agents affecting p53 expression and/or activity
11/22/2012WO2012100229A3 Compositions and methods for cardiovascular disease
11/22/2012WO2011109675A3 Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide
11/22/2012US20120295938 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/22/2012US20120295921 Pyridyl piperidine orexin receptor antagonists
11/22/2012US20120295919 Arylpiperazine opioid receptor antagonists
11/22/2012US20120295917 Imatinib dichloroacetate and anti-cancer agent comprising the same
11/22/2012US20120295915 Azabenzimidazoles as fatty acid synthase inhibitors
11/22/2012US20120295912 Piperazinylpiperidine derivatives as chemokine receptor antagonists
11/22/2012US20120295910 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists
11/22/2012US20120295906 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
11/22/2012US20120295905 New anti-malarial agents
11/22/2012US20120295904 Hematopoietic growth factor mimetic small molecule compounds and their uses
11/22/2012US20120295899 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
11/22/2012US20120295891 Novel substituted triazole derivatives as gamma secretase modulators
11/22/2012US20120295889 3-Arylamino Pyridine Derivatives
11/22/2012US20120295885 Inhibitors of bruton's tyrosine kinase
11/22/2012US20120295874 Coferons and methods of making and using them
11/22/2012US20120295856 Fredericamycin derivatives
11/22/2012US20120294804 Phenylethanolamine-based nmda receptor antagonists
11/22/2012US20120292609 Compound having triphenylamine structure, and organic electroluminescent device
11/22/2012US20120292603 Heterocyclic compound, organic light-emitting device including the heterocyclic compound, and flat display device including the organic light-emitting device
11/22/2012US20120292571 Materials for organic electroluminescent devices
11/22/2012US20120291737 Lubricant compositions containing a heteroaromatic compound
1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 1080